Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Sanofi SA    SNY

SANOFI SA (SNY)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi SA
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following business segments: Pharmaceuticals, Human Vaccines, and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for animal species.

The company was founded on April 28, 1994 and is headquartered in Paris, France.

Number of employees : 106 859 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals32,88886.3%32,27986.5% -1.85%
Vaccines5,23513.7%5,05213.5% -3.49%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States13,51535.5%13,67736.6% +1.19%
Western Europe5,79215.2%---
Asia (Excluding Pacific Region)3,90310.2%---
Latin America3,3638.8%2,7637.4% -17.85%
Eastern Europe and Turkey2,6116.8%---
France2,4816.5%2,4356.5% -1.86%
Africa and Middle-East2,4526.4%---
Japan2,2455.9%1,8635% -17%
Other920.452.4%771.542.1% -16.18%
Rest of the World839.892.2%991.192.7% +18.01%
Europe--7,14519.1%-
Asia (Excluding South Asia)--3,4329.2%-
Africa, Middle East and South Asia--3,0518.2%-
Eurasia--1,2033.2%-
Managers
NameAgeSinceTitle
Olivier Brandicourt MD, PhD612015Chief Executive Officer & Director
Serge Weinberg662009Chairman
Jérôme Contamine602009Chief Financial Officer & EVP-Finance
Elias A. Zerhouni, MD662011President-Global Research & Development
Yong-Jun Liu MD, PhD-2016Head-Global Research & Development
Ameet Nathwani MD, MBA502016Executive Vice President-Medical Affairs
Robert Castaigne, PhD712000Independent Director
Claudie Haigneré MD, PhD602008Independent Director
Carole Piwnica592010Independent Director
Suet-Fern Lee592011Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,292,022,324 1,104,020,927 85.4% 20,084,045 1.6% 85.4%
Shareholders
NameEquities%
Dodge & Cox 67,977,413 2.70%
Barrow, Hanley, Mewhinney & Strauss LLC 29,418,481 1.17%
Franklin Advisers, Inc. 20,688,292 0.82%
Fisher Asset Management LLC 13,638,458 0.54%
Hotchkis & Wiley Capital Management LLC 10,364,345 0.41%
Boston Partners Global Investors, Inc. 8,527,002 0.34%
Invesco Advisers, Inc. 7,418,466 0.29%
Federated Investment Management Co. 5,123,688 0.20%
Managed Account Advisors LLC 4,511,907 0.18%
Fidelity Management & Research Co. 4,291,821 0.17%
Holdings
NameEquities%Valuation
Regeneron Pharmaceuticals (REGN) 23,641,74422.6%11,611,406,148 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%895,528,838 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 10,554,13411.5%841,797,728 USD
Sanofi (SAN) 2,115,4660.17%202,095,692 USD
Zentiva SA (ROSCD) 312,341,64974.9%164,163,647 USD
JHL Biotech Inc (6540) 28,415,11112.9%50,917,322 USD
Myokardia Inc (MYOK) 3,668,89911.7%48,062,577 USD
Voyager Therapeutics Inc (VYGR) 2,477,9419.23%22,202,351 USD
Regulus Therapeutics Inc (RGLS) 5,053,7799.50%4,983,026 USD
SCYNEXIS Inc (SCYX) 1,677,0576.50%3,001,932 USD
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
SANOFI SA15.75%121 388
JOHNSON & JOHNSON17.36%367 897
NOVARTIS9.58%222 704
ROCHE HOLDING LTD.4.94%222 036
PFIZER3.26%199 735
MERCK AND COMPANY6.91%172 151
SANOFI7.63%121 388
BAYER13.03%107 786
GLAXOSMITHKLINE4.03%103 737
ELI LILLY AND COMPANY15.23%93 509
BRISTOL-MYERS SQUIBB COMPANY-5.77%91 334
ABBOTT LABORATORIES32.39%88 239
NOVO NORDISK A/S7.93%85 376
ASTRAZENECA15.45%84 409
ALLERGAN PLC17.33%83 654
SHIRE-12.88%48 229
TAKEDA PHARMACEUTICAL CO LTD19.26%40 723
TEVA PHARMACEUTICAL INDUSTRIES LIMITED-17.14%32 966
ASTELLAS PHARMA INC-15.50%25 393
CHUGAI PHARMACEUTICAL CO., LTD.40.54%23 573
MYLAN NV3.51%21 166
Connections : Sanofi SA
Académie des Technologies
Piasa Holding SAS
Madrigall SA
Council on Foreign Relations, Inc.
Fondation C.Génial
Sanofi-Aventis Europe SAS
Naxos UK Ltd.
Sanofi-Aventis Participations SA
Rickmers Trust Management Pte Ltd.
Total Upstream UK Ltd.
Fondation pour l’Université de Lyon
Sanofi-Aventis U.S. LLC
Academie de l'air et de l'espace
Pharmaceutical Research & Manufacturers of America
Financière Piasa SAS
Sanofi Pasteur Holding SA
Maremma SASU
Sanofi Pasteur Holding Ltd.
Weinberg Capital Partners SAS
National Committee on United States-China Relations, Inc.
Omnium Insurance & Reinsurance Co. Ltd.
Research!America
Fondation Lacoste
King Abdullah University of Science & Technology
L'Oréal Corporate Foundation
Warp Drive Bio LLC
Academie des Sports
Piasa SA
Académie des Sciences et Technologies
Big Red, Inc.
i2O Water Ltd.
NAXOS Capital Managers SARL
Elevance Renewable Sciences, Inc.
Académie Nationale de Médecine
National Academy of Engineering
Select Music & Video Distribution Ltd.
Institute of Medicine
New York State Bar Association
The Johns Hopkins University
Morgan Lewis Stamford LLC
AXA Group Solutions
International Federation of Pharmaceutical Manufacturers A
Nanyang Technological University
International Bar Association
Stamford Corporate Services Pte Ltd.
World Justice Project
AXA Asia SAS
The Children's Aid Society, Inc.
Singapore Bar
Total Gestion Filiales
Singapore Academy of Law
Company contact information
Sanofi
54, rue La Boétie
Paris, Ile-de-France 75008

Phone : +33.1.53.77.40.00
Fax : +33.1.53.77.44.63
Web : www.sanofi.com
© 2017 People , Fundamentals and Ownership